—————— Final Program ——————
The detailed meeting agenda is available at: https://www.iddst.com/iddst2024cn/schedule.asp
* Please keep your speech PPT both in USB drive and email address, no need to send it to the conference side
** Please arrive at the meeting room priori to 20-30 minutes before the session and copy the PPT slides to the computer by yourself
*** The speech is 20-25 min including Q&A time
**** The screen ratio is 16:9, please prepare your PPT according to this
Registration |
Time: 10:00-21:00, September 11, 2024 (Wednesday); Place: Lobby, 2nd Floor, Nanjiao Hotel Shanghai |
Opening Ceremony |
Time: 08:30-09:10, September 12, 2024 (Thursday); Place: Huachang Hall, 1st Floor, Nanjiao Hotel Shanghai |
Plenary Session and High-end Dialogue |
|
Time: 09:10-12:30, September 12, 2024 (Thursday); Place: Huachang Hall, 1st Floor, Nanjiao Hotel Shanghai |
|
|
|
Moderator |
Dr. Ao Zhang, Dean and Distinguished Professor, College of Pharmaceutical Sciences, Shanghai Jiao Tong University, China |
|
|
09:10-09:15 |
Moderator's Introduction |
09:15-09:35 |
Title: Drug Discovery Targeting KRAS Dr. Ao Zhang, Dean and Distinguished Professor, College of Pharmaceutical Sciences, Shanghai Jiao Tong University, China |
09:35-09:55 |
Title: AI-Driven De Novo Design for Discovery of Potential Drug Candidates Targeting SARS-CoV-2 Main Protease Dr. Alexander Tuzikov, Professor, United Institute of Informatics Problems, National Academy of Sciences of Belarus, Belarus |
09:55-10:15 |
Title: Discovery and Biosynthesis of Anti-infective Natural Productsfrom Marine Microorganisms Dr. Jianhua Ju, Dean, School of Pharmaceutical Sciences, Shandong University, China |
10:15-10:35 |
Title: Medical and Industrial Integration Promotes the Progress and Transformation of Theranostics Techniques for Digestive Tract Diseases Dr. Daxiang Cui, Academic Vice President and Dean of the School of Medicine, Henan University, China |
10:35-10:55 |
Title: Getting Enzyme Biotechnology into the Fibers of Modern Society Dr. Jens Erik Nielsen, Senior Vice President, Enzyme, Protein and Strain Engineering Research, Novonesis A/S, Denmark |
10:55-11:15 |
Title: Development of Drugs for Respiratory Viral Infections Utilizing AI-driven Pharmaceutical Models |
11:15-11:35 |
Title: Blocking C5a/C5aR1 Pathway - A Powerful Tool to Control Inflammation Dr. Renfeng Guo, CSO, Inflarx Pharmaceutical Inc., USA & Adjunct Associate Professor, University of Michigan Medical School, USA |
11:35-11:55 |
Title: BL-602, a Cyclophilin Inhibitor, Reduces Fibrosis and Proteinuria in Chronic Kidney Disease |
12:00-12:30 |
High-end Dialogue (Part I) Moderator: Dr. John Xu, President, BIORICH International, USA Topic: The Future of Biopharma: Navigating Innovation, Regulation, and Global Collaboration Guest Speakers: Dr. Lianshan Zhang, Vice General Manager & Global R&D President, Jiangsu Hengrui Pharmaceuticals Co., Ltd., China Dr. Shuangqing Peng, Chief Scientific Officer, Shanghai Medicilon Inc., China Dr. Hongyan Xu, CEO/President, GL Biochem (Shanghai) Ltd.,China Dr. Jizong Li, Director, Shanghai Center of Biomedicine Development, China
High-end Dialogue (Part II) Moderator: Dr. John Xu, President, BIORICH International, USA Topic: Frontier Technologies and Innovative Breakthroughs in Biotherapy Guest Speakers: Dr. Yusheng Wu, Chair/CEO/Founder, TYK Medicines, Inc, China Dr. Yinsheng Zhang, CSO, Wuxi Beita PharmaTech Co., Ltd., China Dr. Gary Xiao, President, Shenzhen Weilan Academy for Translational Medicine, China Dr. Yong Qian, Chairman,BioMedicure, USA & China |
Track 1: Innovative Drug Discovery Science and Technology
IDDST 01: Target Identification & Validation |
|
Time: 14:00-17:40, September 12, 2024 (Thursday); Place: Room 5A, 1st Floor, Nanjiao Hotel Shanghai |
|
Chair |
Dr. Thomas Wittlinger, Professor, Department of Cardiology, Asklepios Hospital, Germany |
Co-chair |
Dr. Narsimha Reddy, Associate Director of Academic Program, School of Science, Western Sydney University, Australia |
14:00-14:05 |
Chair's Introduction |
14:05-14:30
|
Title: Novel Target Discovery and Transformative Therapies for Solid Tumors |
14:30-14:55 |
Title: Clustering Inflammatory Markers with Sociodemographic and Clinical Characteristics of Patients with Diabetes Type 2 |
14:55-15:20
|
Title: The Unique Properties of E2F in Specifically Targeting Cancer Cells |
15:20-15:45
|
Title: Therapeutic Peptides: Paving the Way from Research to Innovative Drugs for Metabolic Diseases |
15:45-16:00 |
Coffee Break |
16:00-16:25 |
Title: Towards the Discovery of Novel Immunomodulatory and Anticancer Polysaccharides from Traditional Medicinal Plants/Mushrooms Dr. Narsimha Reddy, Associate Director of Academic Program, School of Science, Western Sydney University, Australia |
16:25-16:50 |
Title: Development and Validation of a Novel Risk Score to Predict 5-Year Mortality in Patients with Acute Myocardial Infarction in China: A Retrospective Study Dr. Yan Tang, Attending Physician, The First Affiliated Hospital of Nanchang University, China |
16:50-17:15 |
Title: Mast Cells as a Potential Target of Molecular Hydrogen in Regulating the Local Tissue Microenvironment Dr. Dmitrii Atiakshin, Director of the Scientific and Educational Resource Center "Innovative Technologies of Immunophenotyping, Digital Spatial Profiling and Ultrastructural Analysis", RUDN University, Russia |
17:15-17:40 |
Title: Breakthrough Findings Demonstrate That Namodenoson Anti-cancer and Liver Protective Effects Are Mediated via Adiponectin (Video Speech) |
IDDST 02: Disease Models & Applications |
|
Time: 14:00-18:05, September 12, 2024 (Thursday); Place: Room 5B, 1st Floor, Nanjiao Hotel Shanghai |
|
Chair |
Dr. Anil K. Agarwal, Associate Professor of Prosthodontist, Northwestern University, USA |
Co-chair |
Dr. Dazhi Liu, Professor, University of California at Davis, USA |
14:00-14:05 |
Chair's Introduction |
14:05-14:30
|
Title: Animal Models of Human Diseases and the Application in Pharmacodynamic Studies |
14:30-14:55 |
Title: Tumor Suppressor MicroRNA Thearapeutics for Traumatic Brain Injury |
14:55-15:20
|
Title: MIND and Its Magic |
15:20-15:45
|
Title: Adolescent Pre-treatment with the Selective Cannabinoid 1 Receptor Agonist May Lead to Abnormal Hippocampal Theta Synchronization in Adulthood |
15:45-16:00 |
Coffee Break |
16:00-16:25 |
Title: Application of Immunofluorescence Mapping in the Diagnosis of Dystrophic Epidermolysis Bullosa |
16:25-16:50 |
Title: Novel Therapeutic Low Molecular Weight Antibodies for Treatment of Aggressive Esophageal Adenocarcinoma with SMAD4 Loss |
16:50-17:15 |
Title: Creation Panel of Primary Breast Cancer Cell Lines as New Cancer Model for Drug Screening and Basic Research |
17:15-17:40 |
Title: Glycyrrhizic Acid Inhibits SARS-CoV-2 Infection by Blocking Spike Protein-Mediated Cell Attachment |
17:40-18:05 |
Title: Demyelination and Inflammation of CNS are Suppressed by Astragalus Polysaccharides in Experimental Autoimmune Encephalomyelitis Mediated via the PD-1/PD-Ls Pathway Dr. Xiaodong Cheng, Professor & Director, Institute of Clinical Immunology, Yue-Yang Hospital of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, China |
IDDST 03: Drug Discovery Chemistry & Targeted Drug Delivery |
|
Time: 08:30-12:35, September 13, 2024 (Friday); Place: Room 5A, 1st Floor, Nanjiao Hotel Shanghai |
|
Chair |
Dr. Maliha Zahid, Associate Professor, Mayo Clinic, USA |
Co-chair |
Dr. Hongbo Zhang, Professor of Fluid Mechanics, East China University of Science and Technology, China |
08:30-08:35 |
Chair's Introduction |
08:35-09:00
|
Title: Current Challenges and Control Strategies for Polysorbate Degradation in Biopharmaceuticals |
09:00-09:25
|
Title: In Vitro Models by the 3D Bioprinting Coupled with the Organ on a Chip Technology |
09:25-09:50
|
Title: Novel Ester Type Catechins: Chemical Truth and Mechanisms of the Anti-aging Effects of Green Tea |
09:50-10:15
|
Title: Natural Products from Chinese Herbal Medicine: From a Treasure House to Promising Anticancer Leads Dr. Lijuan Deng, Associate Professor, Jinan University, China |
10:15-10:30 |
Coffee Break |
10:30-10:55
|
Title: Cardiac Targeting Peptide: From Discovery to Applications |
10:55-11:20
|
Title: Molecular Modelling of Surface Viral Proteins for the Development of Broad-Spectrum Antiviral Drugs |
11:20-11:45
|
Title: Peptide-Drug Conjugates: Design, Chemistry and Targeted Drug Delivery with Improved Therapeutic Potential Dr. Syed Faheem Askari Rizvi, Postdoctoral Fellow, Lanzhou University, China |
11:45-12:10
|
Title: Exploring the Potential of Triazenes: Antimalarial Activity and Antimicrobial Potential Dr. Frans J. Smit, Senior Lecturer, North-West University, South Africa |
12:10-12:35 |
Title: Sustainable γ-Cyclodextrin Frameworks Containing Ultra-Fine Silver Nanoparticles with Enhanced Antimicrobial Efficacy |
IDDST 04: Pipelines & Clinical Applications |
|
Time: 13:30-17:10, September 13, 2024 (Friday); Place: Room 5A, 1st Floor, Nanjiao Hotel Shanghai |
|
|
|
Chair |
Dr. Adel K. El-Naggar, Professor, University of Texas, MD Anderson Cancer Center, USA |
Co-chair |
Dr. Xiaolei Zhu, Assistant Professor, Johns Hopkins University, USA |
13:30-13:35 |
Chair's Introduction |
13:35-14:00 |
Title: Discovery and Development of Dual Inhibitors of MDM2 and XIAP for Cancer Therapy |
14:00-14:25 |
Title: Anestral Evolution and Genomic Heterogeneity of Salivary Adenoid Cystic Carcinoma: Biological and Therapeutic Implications Dr. Adel K. El-Naggar, Professor, University of Texas, MD Anderson Cancer Center, USA |
14:25-14:50 |
Title: Treatment of Malaria and COVID 19: It Is Never Too Late |
14:50-15:15 |
Title: Pharmacovigilance in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Title: Novel Microglial-Targeted Glutaminase Inhibitors for Chronic Stress-Associated Depression |
15:55-16:20 |
Title: Pgk1 Activators May as a Potential Strategy for Treating Various Neurodegenerative Diseases |
16:20-16:45 |
Title: DEAD-Box RNA Helicase DP103 Regulated SUMO/Acetylation Switch of p53 Determines Response to Docetaxel in ERα-Positive Breast Cancer |
16:45-17:10 |
Title: Cardiolipin Oxidized by ROS from Complex II Acts as a Target of Gasdermin D to Drive Mitochondrial Pore and Heart Dysfunction in Endotoxemia Dr. Yan Tang, Attending Physician, The First Affiliated Hospital of Nanchang University, China |
IDDST 05: Disruptive Technologies & Integrative Services for Pharmaceutical Manufacturing |
|
Time: 08:30-12:10, September 14, 2024 (Saturday); Place: Room 5A, 1st Floor, Nanjiao Hotel Shanghai |
|
|
|
Chair |
Dr. Songhai Chen, Associate Professor, University of Iowa, USA |
Co-chair |
Dr. Robert Marks, Professor, Ben-Gurion University of the Negev, Israel |
08:30-08:35 |
Chair's Introduction |
08:35-09:00 |
Title: AI-Driven Cancer Precision and Therapy Dr. Gary Xiao, President, Shenzhen Weilan Academy for Translational Medicine, China |
09:00-09:25 |
Title: The Extensive Utilization of Isotope-Labeled Compounds in Pharmaceutical R&D Dr. Yinsheng Zhang, CSO, Wuxi Beita PharmaTech Co., Ltd., China |
09:25-09:50 |
Title: Unveiling GPCR Signaling as a Therapeutic Target in Breast Cancer |
09:50-10:15 |
Title: A Study in Instant Mass Analysis for Shortening Experimental Cycles in Drug Discovery Dr. Janshon Zhu, President & CTO, RangerBio Technologies, Ltd. Co., China |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Title: Cap-ImAb – A Platform Enzyme-Based Immunoassay for Determination of Anti-drug Antibodies and Related Immunogenicity in Patients Receiving Biologic Therapy Dr. Robert Marks, Professor, Ben-Gurion University of the Negev, Israel |
10:55-11:20 |
Title: ICH Q14 and USP Chapter <1220>: Historical Perspective and the Path Forward in Analytical QbD |
11:20-11:45 |
Title: Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP |
11:45-12:10 |
Title: Artificial Intelligence in Drug Safety Monitoring |
Track 2: New Strategies and Techniques for Anti-tumor Diagnosis and Treatment
WCC 01: Breakthroughs in Cancer Research |
|
Time: 14:00-17:20, September 12, 2024 (Thursday); Place: Room 6, 1st Floor, Nanjiao Hotel Shanghai |
|
|
|
Chair |
Dr. Yong Qian, Chairman,BioMedicure, USA & China |
Co-Chair |
Dr. Yong Li, Professor, Baylor College of Medicine, USA |
|
|
14:00-14:05 |
Chair's Introduction |
14:05-14:25 |
Title: Mechanisms Underlying Heterogeneous Outcome of Immune Checkpoint Inhibitors in Mouse HNSCC Models |
14:25-14:45 |
Title: MHC Class-I Independent Activation of a Subset of CD8 T Cells Induced by Chemotherapeutic Agent-Treated Cancer Cells |
14:45-15:05 |
Title: Modified Technique 'Modus Spirdonov 1' in Fine-Needle Aspiration Biopsy Under Ultrasonographical Control Dr. Yordan Spirdonov, University Hospital 'Queen Joanna - ISUL', Bulgaria |
15:05-15:25 |
Title: The Matrix Metalloproteinases Expression in the Hypoxic Microenvironment Dr. Gonzalez-Avila Georgina, Head of the Chronic Degenerative Diseases Research Department and the Laboratory of Biomedical Oncology, Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosío Villegas' , Mexico |
15:25-15:45 |
Title: DNA Vaccines for Cancer Prevention and Therapy |
15:45-16:00 |
Coffee Break |
16:00-16:20 |
Title: Electric Fields Regulate in Vitro Surface Phosphatidylserine Exposure of Cancer Cells via a Calcium-Dependent Pathway |
16:20-16:40 |
Title: A New Tumor Marker that can Work as a Diagnostic And Therapeutic Target for Digestive System Neoplasm Dr. Fangfang Chen, Professor, China-Japan Union Hospital of Jilin University, China |
16:40-17:00 |
Title: Universal Cancer Only Marker(UCOM) Discovery and Application for Early Tumor Specific DNA Methylation Detectionr Screening and Detection Dr. Wenqiang Yu, Professor, Institutes of Biomedical Sciences of Fudan University, China |
17:00-17:20 |
Title: Understanding Human Health and Diseases with One's Immune System Evolution |
WCC 02: Clinical Oncology |
|
Time: 08:30-12:30, September 13, 2024 (Friday); Place: Room 6, 1st Floor, Nanjiao Hotel Shanghai |
|
|
|
Chair |
Dr. Pier Paolo Piccaluga, Professor, Universita degli Studi di BolognaI, Italy |
Co-Chair |
Dr. Ulrike Stein, Professor, Charite University Medicine Berlin, Germany |
|
|
08:30-08:35 |
Chair's Introduction |
08:35-08:55 |
Title: Emerging Concepts in Immune Oncology Dr. Catalin Mihalcioiu, Assistant Professor, McGill University Health Centre ( MUHC), Canada |
08:55-09:15 |
Title: Tumor-derived miR-181a-5p-containing Extracellular Vesicles Promote M2-polarization of Macrophage to Secret Taurine for Suppressing Ferroptosis in Prostate Cancer Dr. Yu-Xiang Fang, Associated Investigator, Shanghai Jiao Tong University, China |
09:15-09:35 |
Title: FOXA1 Prolongs S Phase and Promotes Cancer Progression in Non-Small Cell Lung Cancer Through Upregulation of CDC5L and Activation of the ERK1/2 and JAK2 Pathways |
09:35-09:55 |
Title: Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, Statistics and Modeling for Optimal Management Dr. Oleg Kshivets, Head of Surgery Department, Consultant Thoracoabdominal Surgeon and Surgical Oncologist, Bagrationovsk Hospital, Kaliningrad Oblast, Russia ǩ֤ʧ�� |
09:55-10:15 |
Title: Cancer Preventive Properties of an Anthocyanin-Enriched Sweetpotato in the APCMIN Mouse Model |
10:15-10:30 |
Coffee Break |
10:30-10:50 |
Title��Efficacy and Safety of Caspofungin for Patients with Hepatic Insufficiency Dr. Xiaoyun Ran, Physician in the Department of Critical Medicine, The Second Affiliated Hospital of Chongqing Medical University, China |
10:50-11:10 |
Title: Restrict Cancer Metastasis: Translating Gene Discovery into Clinical Application Dr. Ulrike Stein, Professor, Charite University Medicine Berlin, Germany |
11:10-11:30 |
Title: Supine or Prone MDCT Position for Breast Cancer Staging when MRI is Unavailable? A Clinical Study Dr. Yordan Spirdonov, University Hospital 'Queen Joanna - ISUL', Bulgaria |
11:30-11:50 |
Title: Classification of Malignant Lymphomas Dr. Pier Paolo Piccaluga, Associate Professor, Bologna University School of Medicine, Italy |
11:50-12:10 |
Title: Conditional Reprogramming Modeling of Bladder Cancer for Clinical Translation |
12:10-12:30 |
Title: Immune Self Nano for Cancer Clinical Therapy |
WCC 03: Novel Cancer Therapeutics |
|
Time: 08:30-12:10, September 14, 2024 (Saturday); Place: Room 6, 1st Floor, Nanjiao Hotel Shanghai |
|
|
|
Chair |
Dr. Ruola Ning, Professor, University of Rochester, USA |
Co-Chair |
Dr. Tao Lu, CEO, OmniGenex, LLC. USA |
|
|
08:30-08:35 |
Chair's Introduction |
08:35-09:00 |
Title: Cone Beam Breast CT – A Precision Medicine Tool for Breast Cancer Detection, Diagnosis and Image-Guided Treatment Dr. Ruola Ning, Professor, University of Rochester, USA |
09:00-09:25 |
Title: DP-independent E2F Activity as a Target of Cancer Specific Therapeutics Dr. Rinka Nakajima, Kwansei Gakuin University, Japan |
09:25-09:50 |
Title: Side Effects Alleviation of Chemotherapy with Chinese Herbal Medicine Dr. Chi-Feng Cheng, Director, Taipei City United Hospital, Taiwan |
09:50-10:15 |
Title: Novel Antagonistic Anti-PD-1 Antibodies not Blocking the PD-1-PDL-1 Interaction with Potent Anti-Tumor Activity Dr. Giuseppe Pantaleo, Professor, Lausanne University Hospital, Switzerland |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Title: IL-8, A Tumor Microenvironmental Factor, Promotes Prostate Cancer Progression and Therapeutic Resistance Dr. Yong Xu, Professor, Nanjing Medical University, China |
10:55-11:20 |
Title: Anticancer Potentials and Interactome of Bioactive Ingredients in Food-Medicine-Homologous Fruits of Docynia Delavayi, Rosaceae Dr. Phoency F.H. Lai, Professor, University of Shanghai for Science and Technology, China |
11:20-11:45 |
Title: Targeting p53 in Cancer: How Many Angles and How Many Layers? Dr. Tao Lu, CEO, OmniGenex, LLC. USA |
11:45-12: 10 |
Title: High-Resolution Whole-Body Positronium Lifetime Imaging Dr. Jinyi Qi, Professor, University of California, Davis, USA |
Track 3: Antibodies, Vaccines and Advanced Biotherapy
IAVC 01: Latest Research on Antibody Discovery and Antibody-Based Therapy |
|
Time: 08:30-11:20, September 13, 2024 (Friday); Place: Room 5B, 1st Floor, Nanjiao Hotel Shanghai |
|
|
|
Chair |
Dr. Kai Xu, Associate Professor, University of Maryland School of Medicine, USA |
|
|
08:30-08:35 |
Chair's Introduction |
08:35-09:00 |
Title: Antibodies Targeting Abeta Peptide and Tau Protein in Alzheimer's Disease |
09:00-09:25 |
Title: Antibody Increases Cardiac Contraction |
09:25-09:50 |
Title: AK0610, A Protective Human Antibody Against Respiratory Syncytial Virus by Targeting a Prefusion Epitope Across Sites IV and V of the Viral Fusion Glycoproteins |
09:50-10:15 |
Title: Severe Fever with Thrombocytopenia Syndrome Virus Infection and IL�\10 May Be a Potential Target for Reducing SFTS and COVID�\19 Mortality and Could Serve as a Prognostic or Therapeutic Target Dr. Lee Keun Hwa, Professor, Hanyang University College of Medicine, South Korea |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Title: Genome Editing mRNA Nanotherapies Inhibit Cervical Cancer Progression and Regulate the Immunosuppressive Microenvironment for Adoptive T-cell Therapy Dr. Kaijian Ling, Director, Department of Gynecology Women and Children Hospital, Hainan University, China |
10:55-11:20 |
Title: NK Cell Engager for the Treatment of Solid Tumor |
IAVC 02: New Vaccines Design and Development |
|
Time: 08:30-11:45, September 14, 2024 (Saturday); Place: Room 5B, 1st Floor, Nanjiao Hotel Shanghai |
|
|
|
Chair |
Dr. Jinhua Xiang, Research Scientist & Principal Investigator, VA HealthCare and University of Iowa , USA |
|
|
08:30-08:35 |
Chair's Introduction |
08:35-09:00 |
Title: Development of Recombinant Vesicular Stomatitis Virus (rVSV)-based Bivalent Vaccine Against SARS-CoV-2 and Influenza a Virus Dr. Xiaojian Yao, Director, Laboratory of Molecular Human Retrovirology, University of Manitoba, Canada |
09:00-09:25 |
Title: A Multi-Season Randomised Controlled Trial of Advax-adjuvanted Seasonal Influenza Vaccine in Participants with Chronic Disease or Older Age Dr. Dimitar Sajkov, Research Director, Australian Respiratory and Sleep Medicine Institute, Australia |
09:25-09:50 |
Title: Dengue Virus Serotype-specific Inhibition of T cell Responses Is Due to a Single Amino Acid Polymorphism in the Envelope Protein Dr. Jinhua Xiang, Research Scientist & Principal Investigator, VA HealthCare and University of Iowa , USA |
09:50-10:15 |
Title: Development of Improved Vaccine Adjuvants Based on the Natural and Synthetic Saponins Dr. Dayun Zhao, Professor, Shanghai Jiao Tong University, China |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Title: A New Stratey for Vaccine Immune Evaluation System |
10:55-11:20 |
Title: Advancements in CRISPR-based Diagnostics Dr. Fei Deng, Research Associate, University of New South Wales, Australia |
11:20-11:45 |
Title: In Silico Identification of Novel Immunogenic Secreted Proteins of Mycoplasma Bovis from Secretome Data and Experimental Verification |
Track 4: Frontiers of Protein and Peptide Technology and Industrial Application
PepCon 01: Advanced Technology and Industrial Application of Protein & Peptide |
|
Time: 13:30-17:35, September 13, 2024 (Friday); Place: Room 5 B, 1st Floor, Nanjiao Hotel Shanghai |
|
|
|
Chair |
Dr. Yan Li, Associate Director of Bioinformatics, Center for Research Informatics, Biological Science Division, The University of Chicago, USA |
Co-chair |
Dr. Mohammad Uddin, Associate Professor, Mercer University College of Pharmacy, USA |
|
|
13:30-13:35 |
Chair's Introduction |
13:35-14:00 |
Title: Enrichment of Peptides Carrying Post-translational Modifications for Mass Spectrometry Analysis Dr. Yiying Zhu, Director of Chemical Biology Core, Tsinghua University, China |
14:00-14:25 |
Title: Cardiac Targeting Peptide: From Discovery to Applications Dr. Maliha Zahid, Associate Professor/Senior Associate Consultant, Mayo Clinic, USA |
14:25-14:50 |
Title: Automated CyTOF Data Analysis Application (ACDApp) Dr. Yan Li, Associate Director of Bioinformatics, Center for Research Informatics, Biological Science Division, The University of Chicago, USA |
14:50-15:15 |
Title: Revealing the Skin Peptidome of Ranid Frogs Using Mass Spectrometry as the Only Analytical Tool Revealing the Skin Peptidome Dr. Albert Lebedev, Professor, Shenzhen MSU-BIT University, China |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Title: cGMP Commercial Scale Peptide Synthesizer: From Equipment Design Concept to System Qualification Dr. Michael Li, Adjunct Professor, Suzhou University of Science and Technology, China |
15:55-16:20 |
Title: Nanobody Conjugates Bearing Cyclic Cell-penetrating Peptide Modulate Protein Functions Inside Living Cells Dr. Xi Chen, Principal Investigator, The HIT Center for Life Sciences, Harbin Institute of Technology, China |
16:20-16:45 |
Title: The Application of Ultrasensitive Protein Microarray Technology in Biomarker Detection Dr. Aiying Zhang, Professor, Beijing You-An Hospital, Capital Medical University, China |
16:45-17:10 |
Title: A Novel Dual Action Antibiotic Adjuvant Strategy Using Ionic Liquid Towards Synergistic Restoration of Activity in MDRO and Enhancing Antimicrobial Activity against MRSA Dr. Mohammad Uddin, Associate Professor, Mercer University College of Pharmacy, USA |
17:10-17:35 |
Title: Are We Ready to Reclassify Crohn's Disease Using Molecular Classification? Dr. Shahed Kamal, Medical Registrar, Northern Hospital, Australia |
Track 5: Innovative Novel Enzyme Preparation and Industrialization
SEB 01: Emerging Technologies in Enzyme Discovery and Engineering |
|
Time: 13:30-16:20, September 13, 2024 (Friday); Place: Room 6, 1st Floor, Nanjiao Hotel Shanghai |
|
|
|
Chair |
Dr. Weizhuo Xu, Associate Professor, Shenyang Pharmaceutical University, China |
|
|
13:30-13:35 |
Chair's Introduction |
13:35-14:00 |
Title: Biosynthesis of High-value Glycoside Functional Products Dr. Hao Liang, Professor, Beijing University of Chemical Technology, China |
14:00-14:25 |
Title: Assay of Lytic Polysaccharide Monooxygenase Activity in the Culture Supernatant of Recombinant Trichoderma reesei Dr. Gang Liu, Professor, Shenzhen University, China |
14:25-14:50 |
Title: Exploring of the Peroxidase Mechanism of Cytochrome c: From Mitochondrial Function to Biotechnological Applications Dr. Danyun Zeng, Associate Professor, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, China |
14:50-15:15 |
Title: Biosynthesis of Vanillin by Rational Design of enoyl-CoA hydratase/lyase Dr. Weizhuo Xu, Associate Professor, Shenyang Pharmaceutical University, China |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Title: Activation of Phospholipase A2 by Prostaglandin in vitro Dr. Rohit Sood, Director, Spinverse Oy, Finland |
15:55-16:20 |
Title: Family IV Carboxylesterases from Environmental Metagenomes and Bacterial Genomes for Polyesterase Activity Ms. Hairong Ma, Bangor University, UK |
Track 6: Advanced Diagnosis and Treatment of Diabetes and Obesity Metabolic Diseases
WCDO 01: Diabetes, Obesity and Metabolic Diseases |
|
Time: 14:00-16:50, September 12, 2024 (Thursday); Place: Room 4, 1st Floor, Shanghai, China |
|
|
|
Chair |
Dr. Shunlin Ren, Associate Professor, Department of Internal Medicine, Virginia Commonwealth University, USA |
|
|
14:00-14:05 |
Chair's Introduction |
14:05-14:30
|
Title: System Genetic Approach Reveals the Role of Alox12 in Diet-Induced Obesity in BXD Mice |
14:30-14:55 |
Title: Early Diagnosis for Early Treatment in Cystic Fibrosis (CF) Dr. Silvia Gartner, Professor, Hospital Universitari Vall d´Hebron. Barcleona, Spain |
14:55-15:20
|
Title: 25HC3S: Endogenous Epigenetic Regulator for Treating Chronic & Acute Liver Diseases |
15:20-15:45
|
Title: Two Novel Candidate Genes Identified in Adults from the Newfoundland Population with Addictive Tendencies Towards Food |
15:45-16:00 |
Coffee Break |
16:00-16:25 |
Title: Sorbs2 Deficiency and Coronary BK Channelopathy in Diabetes |
16:25-16:50 |
Title: Decoding regeneration using computer designed proteins Dr. Hannele Ruohola-Baker, Professor & Associate Director, Institute for Stem Cell and Regenerative Medicine (ISCRM), University of Washington, USA |
Posters and Papers |
|
01 |
Title: Creation Panel of Primary Breast Cancer Cell Lines as New Cancer Model for Drug Screening and Basic Research Dr. Xiaowei Dou, Research Associate, Clinical Research Center, The Affiliated Hospital of Guizhou Medical University, China |
02 |
Title: Novel pH-Responsive Peptide-Paclitaxcel Conjugate with Improved Therapeutic Potentials Against Glioblastoma Dr. Syed Faheem Askari Rizvi, Postdoctoral Fellow, Lanzhou University, China |
03 |
Title: Enhanced Detection of Ligand-PPARγ Binding Based on Surface Plasmon Resonance through Complexation with SRC1- or NCOR2-Related Polypeptide Dr. Changzhen Liu, Professor, Experimental Research Center, China Academy of Chinese Medical Sciences, China |
04 |
Title: Divergent Molecular Assembly and Catalytic Mechanisms between Bacterial and Archaeal RNase P in pre-tRNA Cleavage Dr. Xiaoge Liang, Shanghai Jiao Tong University, China |
05 |
Title: Disulfiram/Cu Increase the Anti-Tumor Response of Chemo-Immunotherapy by Targeting Pancreatic Cancer Stem Cells |
06 |
Title: Development of Boron-Containing Multifunctional Nanoconstructs Based on Modified Forms of Albumin for Theranostics of Malignant Tumors Ms. Meiling Wang, Novosibirsk State University, Russia |
07 |
Title: Study on the Hypoglycemic Mechanism of Extracts from Rhinacanthus nasutus (L.) Kurz Based on Serum Pharmacochemistry, Network Pharmacology, And Experimental Verification Ms. Junyu Liu, PhD.Candidate, Tianjin University, China |
08 |
Title: Steam Explosion Improves Extractability, Antioxidant Activity and α-glucosidase Inhibitory Activity of the Constituents of Java Tea (Clerodendranthus Spicatus) Ms. Jia Wang, PhD.Candidate, Tianjin University, China |
09 |
Title: Two genes PA5178 and PA5489 Are Components of the Regulon for the ECF Sigma Factor AlgT/U in Pseudomonas Aeruginosa. A Close Look at Possibilities of up Regulating These Two Genes in an Alginate + or Mucoid Phenotype |
----------------------Contact Us---------------------- |